بيكالوتاميد تيڤع ١٥٠ ملغ
teva pharmaceutical indust.ltd - bicalutamide 150 mg - tablets - bicalutamide - in patients with locally advanced prostate cancer (t3-t4 any n m0 t1-t2 n+ m0) bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.
anagastra 20 mg 500 comprimits gastrorres blist
anagastra 40 mg 500 comprimits gastrorres blist
anagastra 40 mg 1 vial
anagastra 40 mg 14 comprimits gastrorresist blist
anagastra 40 mg 28 comprimits gastrorresist blist
anagastra 40 mg 28 comprimits gastrorresistents
anagastra 40 mg 28 comprimits gastrorresistents
anagastra 20 mg 28 comprimits recoberts
anagastra 20 mg 28 comprimits recoberts